150 related articles for article (PubMed ID: 36252336)
21. Enhanced in vitro cytotoxicity and antitumor activity in vivo of iridium(III) complexes liposomes targeting endoplasmic reticulum and mitochondria.
Li W; Wu X; Liu H; Shi C; Yuan Y; Bai L; Liao X; Zhang Y; Liu Y
J Inorg Biochem; 2022 Aug; 233():111868. PubMed ID: 35636300
[TBL] [Abstract][Full Text] [Related]
22. Mitochondria-targeted iridium(III) complexes encapsulated in liposome induce cell death through ferroptosis and gasdermin-mediated pyroptosis.
Huang C; Yuan Y; Li G; Tian S; Hu H; Chen J; Liang L; Wang Y; Liu Y
Eur J Med Chem; 2024 Feb; 265():116112. PubMed ID: 38183779
[TBL] [Abstract][Full Text] [Related]
23. The induction of apoptosis in SGC-7901 cells through the ROS-mediated mitochondrial dysfunction pathway by a Ir(III) complex.
Zhang C; Lai SH; Zeng CC; Tang B; Wan D; Xing DG; Liu YJ
J Biol Inorg Chem; 2016 Dec; 21(8):1047-1060. PubMed ID: 27796592
[TBL] [Abstract][Full Text] [Related]
24. Light activation of iridium(III) complexes driving ROS production and DNA damage enhances anticancer activity in A549 cells.
Li W; Shi C; Wu X; Zhang Y; Liu H; Wang X; Huang C; Liang L; Liu Y
J Inorg Biochem; 2022 Nov; 236():111977. PubMed ID: 36030672
[TBL] [Abstract][Full Text] [Related]
25. Significant increase of anticancer efficacy in vitro and in vivo of liposome entrapped ruthenium(II) polypyridyl complexes.
Chen Y; Li W; Yang Y; Zhong R; Hu H; Huang C; Chen J; Liang L; Liu Y
Eur J Med Chem; 2023 Sep; 257():115541. PubMed ID: 37295162
[TBL] [Abstract][Full Text] [Related]
26. Iridium(III) complex induces apoptosis in HeLa cells by regulating mitochondrial and PI3K/AKT signaling pathways: In vitro and in vivo experiments.
He SF; Han WC; Shao YY; Zhang HB; Hong WX; Yang QH; Zhang YQ; He RR; Sun J
Bioorg Chem; 2023 Dec; 141():106867. PubMed ID: 37734195
[TBL] [Abstract][Full Text] [Related]
27. Liposomes encapsulated iridium(III) polypyridyl complexes enhance anticancer activity in vitro and in vivo.
Bai L; Fei WD; Gu YY; He M; Du F; Zhang WY; Yang LL; Liu YJ
J Inorg Biochem; 2020 Apr; 205():111014. PubMed ID: 32044395
[TBL] [Abstract][Full Text] [Related]
28. Liposome as drug delivery system enhance anticancer activity of iridium (III) complex.
Gu Y; Bai L; Zhang Y; Zhang H; Xing D; Tian L; Zhou Y; Hao J; Liu Y
J Liposome Res; 2021 Dec; 31(4):342-355. PubMed ID: 32892672
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and anticancer activity in vitro and in vivo evaluation of iridium(III) complexes on mouse melanoma B16 cells.
Yuan Y; Shi C; Wu X; Li W; Huang C; Liang L; Chen J; Wang Y; Liu Y
J Inorg Biochem; 2022 Jul; 232():111820. PubMed ID: 35421766
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of anticancer effects in vitro of new iridium(III) complexes targeting the mitochondria.
Hao J; Zhang H; Tian L; Yang L; Zhou Y; Zhang Y; Liu Y; Xing D
J Inorg Biochem; 2021 Aug; 221():111465. PubMed ID: 33989986
[TBL] [Abstract][Full Text] [Related]
31. Photoinduced anticancer activity studies of iridium(III) complexes targeting mitochondria and tubules.
Zhang WY; Yi QY; Wang YJ; Du F; He M; Tang B; Wan D; Liu YJ; Huang HL
Eur J Med Chem; 2018 May; 151():568-584. PubMed ID: 29656200
[TBL] [Abstract][Full Text] [Related]
32. An iridium (III) complex as potent anticancer agent induces apoptosis and autophagy in B16 cells through inhibition of the AKT/mTOR pathway.
Tang B; Wan D; Wang YJ; Yi QY; Guo BH; Liu YJ
Eur J Med Chem; 2018 Feb; 145():302-314. PubMed ID: 29331753
[TBL] [Abstract][Full Text] [Related]
33. Design, Synthesis, and Anticancer Effect Studies of Iridium(III) Polypyridyl Complexes against SGC-7901 Cells.
Zhang LX; Gu YY; Wang YJ; Bai L; Du F; Zhang WY; He M; Liu YJ; Chen YZ
Molecules; 2019 Aug; 24(17):. PubMed ID: 31466318
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, characterization, molecular docking, RNA-sequence and anticancer efficacy evaluation in vitro of ruthenium(II) complexes on B16 cells.
Huang C; Zhang H; Yang Y; Liu H; Chen J; Wang Y; Liang L; Hu H; Liu Y
J Inorg Biochem; 2023 Oct; 247():112329. PubMed ID: 37478780
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, characterization and irradiation enhances anticancer activity of liposome-loaded iridium(III) complexes.
Tian S; Nie Q; Chen H; Liang L; Hu H; Tang S; Yang J; Liu Y; Yin H
J Inorg Biochem; 2024 Jul; 256():112549. PubMed ID: 38579631
[TBL] [Abstract][Full Text] [Related]
36. Identification of two mitochondrial-targeting cyclometalated iridium(III) complexes as potent anti-glioma stem cells agents.
Peng W; Hegazy AM; Jiang N; Chen X; Qi HX; Zhao XD; Pu J; Ye RR; Li RT
J Inorg Biochem; 2020 Feb; 203():110909. PubMed ID: 31689591
[TBL] [Abstract][Full Text] [Related]
37. Mitochondria-targeted cyclometalated iridium-β-carboline complexes as potent non-small cell lung cancer therapeutic agents.
Chen J; Guo X; Li D; Tang H; Gao J; Yu W; Zhu X; Sun Z; Huang Z; Chen L
Metallomics; 2023 Jun; 15(6):. PubMed ID: 37204038
[TBL] [Abstract][Full Text] [Related]
38. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
[TBL] [Abstract][Full Text] [Related]
39. Studies of anticancer activity in vivo and in vitro behaviors of liposomes encapsulated iridium(III) complex.
Gu Y; Wen H; Zhang Y; Bai L; Zhou Y; Zhang H; Tian L; Hao J; Liu Y
J Biol Inorg Chem; 2021 Feb; 26(1):109-122. PubMed ID: 33475857
[TBL] [Abstract][Full Text] [Related]
40. Lysosome-targeted cyclometalated iridium(III) complexes: JMJD inhibition, dual induction of apoptosis, and autophagy.
Lu JJ; Ma XR; Xie K; Chen MR; Huang B; Li RT; Ye RR
Metallomics; 2022 Sep; 14(9):. PubMed ID: 36073756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
